Live Breaking News & Updates on Patients With Facial Acne

To date, approximately 50% enrolled patients have completed 12-week treatment and all enrolled patients are expected to complete 12-week treatment by the end. ....

United States , Hong Kong , Leihong Xiang , Jinzij Wu , Physician Of Dermatological Department , Fudan University , Hong Kong Stock Exchange , Institute Of Dermatology , Drug Administration , Dermatology Division Of Chinese Medical Doctor Association , Ascletis Pharma Inc , Ascletis Pharma , Global Assessment , Chief Physician , Dermatological Department , Huashan Hospital , Executive Deputy Director , Deputy Director , Dermatology Division , Chinese Medical Doctor Association , Topical Clascoterone Cream , Patients With Facial Acne , Two Phase , North America , Ascletis Pharma Inc ,